Review: could Herceptin cause Peripheral sensory neuropathy?
Summary: Peripheral sensory neuropathy is found among people who take Herceptin, especially for people who are female, 50-59 old, have been taking the drug for < 1 month, also take medication Paclitaxel, and have Breast cancer.
We study 10,358 people who have side effects while taking Herceptin from FDA and social media. Among them, 15 have Peripheral sensory neuropathy. Find out below who they are, when they have Peripheral sensory neuropathy and more.
You are not alone: join a support group for people who take Herceptin and have Peripheral sensory neuropathy >>>
Herceptin has active ingredients of trastuzumab. It is often used in breast cancer. (latest outcomes from 10,453 Herceptin users)
Peripheral sensory neuropathy
Peripheral sensory neuropathy (damage to one or more of your peripheral nerves) has been reported by people with multiple myeloma, breast cancer, rheumatoid arthritis, osteoporosis, high blood pressure. (latest reports from 2,046 Peripheral sensory neuropathy patients)
On Apr, 15, 2015: 10,358 people reported to have side effects when taking Herceptin. Among them, 15 people (0.14%) have Peripheral Sensory Neuropathy.
Time on Herceptin when people have Peripheral sensory neuropathy * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Peripheral sensory neuropathy||75.00%||12.50%||0.00%||12.50%||0.00%||0.00%||0.00% |
Gender of people who have Peripheral sensory neuropathy when taking Herceptin * :
|Peripheral sensory neuropathy||87.50%||12.50% |
Age of people who have Peripheral sensory neuropathy when taking Herceptin * :
|Peripheral sensory neuropathy||0.00%||0.00%||0.00%||0.00%||21.05%||21.05%||36.84%||21.05% |
Severity of Peripheral sensory neuropathy when taking Herceptin ** :
How people recovered from Peripheral sensory neuropathy ** :
Top conditions involved for these people * :
- Breast cancer (11 people, 73.33%)
- Breast cancer metastatic (5 people, 33.33%)
- Gastric cancer (2 people, 13.33%)
- Neoplasm malignant (1 people, 6.67%)
Top co-used drugs for these people * :
- Paclitaxel (12 people, 80.00%)
- Cyclophosphamide (7 people, 46.67%)
- Doxorubicin hcl (6 people, 40.00%)
- Tamoxifen citrate (4 people, 26.67%)
- Leucovorin calcium (3 people, 20.00%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Get connected: join our support group of herceptin and peripheral sensory neuropathy on
Citations of the study:
Do you have Peripheral Sensory Neuropathy while taking Herceptin?
You are not alone! Join a support group on :
- support group for people who take Herceptin and have Peripheral Sensory Neuropathy
- support group for people who take Herceptin
- support group for people who have Peripheral Sensory Neuropathy
Drugs in real world that are associated with:
Could your condition cause:
Recent Herceptin related drug comparison:
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.